Fibromyalgia 2: Tailoring Therapy and Implementing a Multi-Disciplinary Team Approach

Title:

Fibromyalgia 2: Tailoring Therapy and Implementing a Multi-Disciplinary Team Approach

Topic: Pain Management
Relevant Terms: Depression, Fibromyalgia, Pain, Rheumatology, Systemic Lupus Erythematosus
Primary Audience: Primary Care Physicians; Rheumatologists; Neurologists; Pain Physicians; Nurse Practitioners; Physician Assistants; and Psychiatrists
Launch Date: 25-Nov-09
Credits: 0.5 AMA PRA Category 1 Credit
Expiration Date: 24-Nov-10

Learning Objectives

Upon completion of the activity, participants should be able to:

  1. Recognize fibromyalgia syndrome (FMS) from other disorders though better understanding of diagnostic criteria.
  2. Apply current clinical practice guidelines to diagnose and treat FMS patients.
  3. Properly identify and address behavioral, psychological, and social factors affecting patients with FMS.
  4. Develop appropriate pharmacological and behavioral treatment interventions tailored to the individual needs of patients with FMS to better manage pain and improve quality of life.
  5. Implement a multi-disciplinary team approach to improve pain management and patient compliance.

Faculty

Michael R. Clark, MD, MPH
Associate Professor
The Johns Hopkins University School of Medicine
Director
Adolph Meyer Chronic Pain Treatment Programs
Department of Psychiatry and Behavioral Sciences
Baltimore, Maryland
Perry G. Fine, MD
Professor of Anesthesiology
Pain Research Center, School of Medicine
University of Utah
Salt Lake City, Utah

PREREQUISITES
There are no prerequisites for participation.

ESTIMATED TIME TO COMPLETE ACTIVITY 0.5 hours of participation.

STATEMENT of NEED
Since patients with FMS are now more commonly seen in primary care settings, we have identified a significant need for the education of primary care physicians regarding the proper diagnosis and optimal management of patients with FMS, and specifically, to increase awareness of the needs of patients with FMS, to encourage a more multi-disciplinary approach in managing and treating pain, and to better identify and treat the various subtypes of patients with FMS. Neurologists and rheumatologists currently treating patients with FMS would also benefit from participating and collaborating in more continuing education programs highlighting the more recent advances on the diagnosis and management of the disease.

SPONSORSHIP STATEMENT

Presented by The Johns Hopkins University School of Medicine.
John Hopkins

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), it is the policy of the Johns Hopkins University School of Medicine to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The presenting faculty reported the following:
Michael R. Clark, MD, MPH reports being a consultant to and is on the speaker's bureau for Eli Lilly and Company.
Perry G. Fine, MD has nothing to disclose.

Note: Grants to investigators at The Johns Hopkins University are negotiated and administered by the institution which receives the grants, typically through the Office of Research Administration. Individual investigators who participate in the sponsored project(s) are not directly compensated by the sponsor, but may receive salary or other support from the institution to support their effort on the project(s).

OFF LABEL PRODUCT DISCUSSION
No speaker has indicated that their presentation will include information on off-label products.

DISCLAIMER
The opinions and recommendations expressed by faculty and other experts whose input is included in this program are their own. Use of Johns Hopkins University School of Medicine name implies review of educational format design and approach. Please review the complete prescribing information of specific drugs or combination of drugs, including indications, contraindications, warnings and adverse effects before administering pharmacologic therapy to patients.

CREDIT DESIGNATION STATEMENT
The Johns Hopkins University School of Medicine designates this educational activity for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

ACCREDITATION STATEMENT
The Johns Hopkins University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

STATEMENT OF RESPONSIBILITY
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

ACKNOWLEDGEMENT
This activity is supported by an educational grant from Pfizer Inc.

INTERNET CME POLICY
The Office of Continuing Medical Education (CME) at the Johns Hopkins University School of Medicine is committed to protect the privacy of its members and customers. Johns Hopkins University SOM CME maintains its Internet site as an information resource and service for physicians, other health professionals and the public. Continuing Medical Education at the Johns Hopkins University School of Medicine will keep your personal and credit information confidential when you participate in a CME Internet based program. Your information will never be given to anyone outside of the Johns Hopkins University School of Medicine's CME program. CME collects only the information necessary to provide you with the services that you request.

To Obtain CME Credits
This activity includes text, graphics, and may include multi-media features. Click on all of the medical education activity links and review the content presented.
  1. Read, complete, and submit answers to the examination and evaluation questions online.
  2. You must pass the examination with a score of 70% or higher in order to receive credit for this activity.
  3. Once you have successfully completed the examination & evaluation, a certificate will be automatically generated.

COURSE VIEWING REQUIREMENTS

PC
Internet Explorer (v6 or greater), or Firefox
MAC
Safari

Release Date: November 25, 2009
Expiration Date: November 24, 2010